Olisiko tuosta apua myös homesairaille?

Monia muita, toisten sairauksien, lääkkeitä on kokeilut joillekin homesairaille.

Keuhkolääkäri kokeili minulle keuhkoahtaumataudin hoitoon tehoavaa Spirivaa. Minulle siitä ei ollut apua. Minulla ei ole (vielä) keuhkoahtaumatautia enkä tupakoi. Jotkut homesairaat vaikeaa astmaa sairastavat ovat saaneet siitä apua.

Tässä yksi linkki, jossa kannattaa vierailla:

http://www.az-air.com/news/news_read.asp?id=4608


Chronic bronchitis leads to COPD in half of smokers

Chronic bronchitis leads to COPD in half of smokers Chronic bronchitis occurs in more than two fifths of smokers, and half of these cases go on to develop chronic obstructive pulmonary disease (COPD) Finnish study findings indicate.
The study of nearly 2000 men, with up to 40 years' follow-up, also showed that chronic bronchitis is associated with lower pulmonary function and increased mortality...

Chronic bronchitis leads to COPD in half of smokers
Nov 09, 2006 - Chronic bronchitis occurs in more than two fifths of smokers, and half of these cases go on to develop chronic obstructive pulmonary disease (COPD) Finnish study findings indicate.

The study of nearly 2000 men, with up to 40 years’ follow-up, also showed that chronic bronchitis is associated with lower pulmonary function and increased mortality.

“At present, there are still no studies describing the long-term cumulative incidence of chronic bronchitis,” say Margit Pelkonen (University of Kuopio) and colleagues.

The researchers therefore set out to estimate the 30-year cumulative incidence of chronic bronchitis and airflow obstruction, and examine the long-term relationship between chronic bronchitis and pulmonary function.

To do this, they studied 1711 middle-aged men included in two Finnish cohorts of the Seven Countries Study in 1959, and followed them until 2000.

Chronic bronchitis was assessed using questionnaires and spirometry was performed at re-examinations in 1964, 1969, 1974, 1984, 1989, and 2000.
Deaths were established from official death certificates and 40-year mortality was examined.

The results showed that, by the age of 75 years, the cumulative incidence of chronic bronchitis was 42% in continuous smokers, compared with 26% in ex-smokers, and 22% in never-smokers. The incidence leveled off at 65 years of age.

Meanwhile the cumulative incidence of COPD was 32% in continuous smokers, compared with 14% in ex-smokers, and 12% in never-smokers. The cumulative incidence of COPD and chronic bronchitis combined was 19% in continuous smokers, 74% of whom developed chronic bronchitis first. Only 4.5% of ex-smokers and 4.0% of never-smokers had both conditions.

Over the whole follow-up period, chronic bronchitis sufferers had on average a 252 ml lower FEV0.75 than those without bronchitis, and the decrease attributable to chronic bronchitis was greatest among those with persistent symptoms and in smokers.

Those individuals with chronic bronchitis had increased mortality, with a hazard ratio for all-cause death of 1.30, after adjustment for lung function.

Further analysis revealed that continuous smokers with chronic bronchitis who decreased their daily cigarette consumption had a reduced HR for all-cause mortality of 0.66, corresponding to a 2.4-year longer median survival, relative to those who did not alter their cigarette consumption.

“In conclusion, in the present study, two in five smokers had chronic bronchitis,” the authors conclude in the journal Chest.

“Thus, checking for the symptoms of chronic bronchitis is a straightforward way to evaluate the effects of smoking. In smokers, smoking cessation is the most effective way to reduce disease progression.”


Chest 2006; 130: 1129-1137
Read more      
      
0202
Äänestä

Muut lukivat myös

Vastaukset

Vanhimmat

Ei vielä vastauksia

Aloittaja odottaa vastauksia. Kerro oma näkemyksesi ensimmäisenä.

Kommentoi aloitusta


hilkkaliisa kirjoitti:

Monia muita, toisten sairauksien, lääkkeitä on kokeilut joillekin homesairaille.

Keuhkolääkäri kokeili minulle keuhkoahtaumataudin hoitoon tehoavaa Spirivaa. Minulle siitä ei ollut apua. Minulla ei ole (vielä) keuhkoahtaumatautia enkä tupakoi. Jotkut homesairaat vaikeaa astmaa sairastavat ovat saaneet siitä apua.

Tässä yksi linkki, jossa kannattaa vierailla:

http://www.az-air.com/news/news_read.asp?id=4608


Chronic bronchitis leads to COPD in half of smokers

Chronic bronchitis leads to COPD in half of smokers Chronic bronchitis occurs in more than two fifths of smokers, and half of these cases go on to develop chronic obstructive pulmonary disease (COPD) Finnish study findings indicate.
The study of nearly 2000 men, with up to 40 years' follow-up, also showed that chronic bronchitis is associated with lower pulmonary function and increased mortality...

Chronic bronchitis leads to COPD in half of smokers
Nov 09, 2006 - Chronic bronchitis occurs in more than two fifths of smokers, and half of these cases go on to develop chronic obstructive pulmonary disease (COPD) Finnish study findings indicate.

The study of nearly 2000 men, with up to 40 years’ follow-up, also showed that chronic bronchitis is associated with lower pulmonary function and increased mortality.

“At present, there are still no studies describing the long-term cumulative incidence of chronic bronchitis,” say Margit Pelkonen (University of Kuopio) and colleagues.

The researchers therefore set out to estimate the 30-year cumulative incidence of chronic bronchitis and airflow obstruction, and examine the long-term relationship between chronic bronchitis and pulmonary function.

To do this, they studied 1711 middle-aged men included in two Finnish cohorts of the Seven Countries Study in 1959, and followed them until 2000.

Chronic bronchitis was assessed using questionnaires and spirometry was performed at re-examinations in 1964, 1969, 1974, 1984, 1989, and 2000.
Deaths were established from official death certificates and 40-year mortality was examined.

The results showed that, by the age of 75 years, the cumulative incidence of chronic bronchitis was 42% in continuous smokers, compared with 26% in ex-smokers, and 22% in never-smokers. The incidence leveled off at 65 years of age.

Meanwhile the cumulative incidence of COPD was 32% in continuous smokers, compared with 14% in ex-smokers, and 12% in never-smokers. The cumulative incidence of COPD and chronic bronchitis combined was 19% in continuous smokers, 74% of whom developed chronic bronchitis first. Only 4.5% of ex-smokers and 4.0% of never-smokers had both conditions.

Over the whole follow-up period, chronic bronchitis sufferers had on average a 252 ml lower FEV0.75 than those without bronchitis, and the decrease attributable to chronic bronchitis was greatest among those with persistent symptoms and in smokers.

Those individuals with chronic bronchitis had increased mortality, with a hazard ratio for all-cause death of 1.30, after adjustment for lung function.

Further analysis revealed that continuous smokers with chronic bronchitis who decreased their daily cigarette consumption had a reduced HR for all-cause mortality of 0.66, corresponding to a 2.4-year longer median survival, relative to those who did not alter their cigarette consumption.

“In conclusion, in the present study, two in five smokers had chronic bronchitis,” the authors conclude in the journal Chest.

“Thus, checking for the symptoms of chronic bronchitis is a straightforward way to evaluate the effects of smoking. In smokers, smoking cessation is the most effective way to reduce disease progression.”


Chest 2006; 130: 1129-1137
Read more      
      

Anonyymi
5000

Ilmoita asiaton sisältö

  • Sisältää materiaalia, joka on loukkaavaa, herjaavaa, rasistista, uhkailevaa tai ahdistelevaa.

  • Materiaali sisältää nimiä, yhteystietoja tai muita henkilökohtaisia tietoja. Julkisuuden henkilöistä, julkisissa viroissa toimivista ihmisistä sekä yritysten vastuuhenkilöistä saa keskustella työhön liittyen. Myös yksityiselämään liittyvistä asioista voi keskustella siltä osin, kuin niistä on julkisesti kerrottu.

  • Sisältää lapsille haitallista tai heiltä kiellettyä materiaalia. Seksuaalinen sisältö on sallittua aiheeseen tarkoitetuilla palstoilla, joiden ikäraja on 18 vuotta.

  • Lainvastaista sisältöä voi olla mm. yksityiselämää loukkaavan tiedon levitys, kiihottaminen kansanryhmää vastaan, laiton uhkaaminen, alaikäisiin liittyvä seksuaalinen sisältö/grooming, petokset, identiteettivarkaudet, kunnianloukkaukset ja tekijänoikeusrikkomukset.

  • Sisältö ei liity palstan tai keskusteluketjun aiheeseen.

  • Viesti ei ole suomea tai ruotsia (pl. International Forums), se sisältää mainontaa, se sisältää tekijänoikeuksin suojattua materiaalia, se on massapostitus tai jokin muu syy.

Jaa keskustelu